New and Evolving Therapeutic Targets in Lung Cancer: Expert Guidance in Incorporating Biomarker Testing to Deliver Precision Therapy

Download this short summary slideset of key takeaway points from a live CCO meeting series on the evolving use of biomarkers for precision therapy in lung cancer.

Eric Q. Konnick, MD, MS Nathan Pennell, MD, PhD Released: May 29, 2020

Download this short summary slideset of key takeaways from a live CCO Webinar focused on the use of new biomarkers critical to lung cancer care today.

Leora Horn, MD, MSc, FRCPC Edward S. Kim, MD, FACP Released: June 26, 2020

Download these slides from our live meeting series to gain expert insights on how to integrate new and emerging molecular targets into the care of your patients with lung cancer.

Eric Q. Konnick, MD, MS Nathan Pennell, MD, PhD Released: May 5, 2020

Download this slideset on new and emerging molecular targets critical to lung cancer care, including expert insight on NTRK fusions, RET fusions, and MET exon 14 skipping mutations.

Leora Horn, MD, MSc, FRCPC Edward S. Kim, MD, FACP Released: June 25, 2020

Download this slideset for expert insights on the role of biomarkers in the optimal use of immunotherapy in the care of patients with NSCLC.

Leora Horn, MD, MSc, FRCPC Edward S. Kim, MD, FACP Released: June 25, 2020

Which emerging biomarkers have the most potential to affect personalized care of our patients with NSCLC? Read my thoughts on testing for and targeting RET, MET exon 14, and more.

Todd M. Bauer, MD Released: February 28, 2020

As targeted therapy prolongs survival in our patients with oncogene-driven NSCLC, CNS metastases and leptomeningeal carcinomatosis are more likely to develop as part of the disease course. Read my thoughts on what factors I consider when treating these challenging disease manifestations.

Lyudmila Bazhenova, MD Released: April 28, 2020

Vamsidhar Velcheti, MD, provides his thoughts on the clinical implications of the recent approval of selpercatinib for RET fusion–positive NSCLC in this commentary.

Vamsidhar Velcheti, MD Released: June 25, 2020

Download this PDF resource for clinical insights on new and established clinical biomarkers guiding NSCLC management, including best testing practices.